Healthpeak Properties IncHealthpeak raised its 2026 EPS and FFO guidance for the second time this year on portfolio sales and buybacks/debt paydown.
Healthpeak Properties raised its full-year 2026 guidance for the second time this year, now expecting diluted earnings per share of $0.48 to $0.52, up from $0.46 to $0.50, and diluted FFO as Adjusted of $1.73 to $1.77, two cents higher at the midpoint than its prior outlook. The healthcare real estate owner signed 1.6 million square feet of new and renewal leases in the quarter, lifting outpatient medical occupancy 20 basis points to 90.7% and lab occupancy 80 basis points to 78.5%. Growth was led by Janus Living, the senior housing operator Healthpeak controls with a 73.6% stake, where revenue jumped 45% year over year to $216 million and Adjusted EBITDA rose 34% to $79 million, with same-store margins expanding 250 basis points. Healthpeak funded buybacks and debt paydown largely by selling stakes in existing buildings, including July's recapitalization that sold a 49% stake in an 86-property outpatient medical portfolio to Brookfield for roughly $1.025 billion at a 5.9% cap rate, part of $1.4 billion of proceeds generated in the quarter and through August 3. Lab same-store net operating income fell 3.2%, the only one of Healthpeak's three core businesses to shrink, holding total company-wide same-store NOI growth to 1.8%.
Healthpeak Properties IncHealthpeak raised its 2026 EPS and FFO guidance for the second time this year on portfolio sales and buybacks/debt paydown.
Janus Living, Inc.Janus Living, 73.6%-owned by Healthpeak, drove growth with revenue up 45% to $216M and Adjusted EBITDA up 34% to $79M.
Brookfield Asset Management Ltd.Brookfield bought a 49% stake in Healthpeak's 86-property outpatient medical portfolio for ~$1.025B, a transaction mention but not a driver of its own results.